Full Text View
Tabular View
No Study Results Posted
Related Studies
Atherosclerosis Risk in Communities (ARIC)
This study has been completed.
First Received: May 25, 2000   Last Updated: April 13, 2009   History of Changes
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00005131
  Purpose

To measure associations of established and suspected coronary heart disease risk factors with both atherosclerosis and new coronary heart disease events in representative cohorts from four diverse United States communities. To compare the communities with respect to risk factors, medical care, atherosclerosis, and coronary heart disease incidence. ARIC has two components in each community: study of representative cohorts of adult men and women, and community surveillance of morbidity and mortality.


Condition Phase
Atherosclerosis
Coronary Disease
Coronary Heart Disease Risk Reduction
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Heart Failure, Congestive
Heart Failure
N/A

MedlinePlus related topics: Coronary Artery Disease Diabetes Heart Diseases Heart Failure
U.S. FDA Resources
Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: July 1985
Study Completion Date: January 2007
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00005131

Sponsors and Collaborators
Investigators
Investigator: Christie Ballantyne Baylor College of Medicine
Investigator: Lloyd Chambless University of North Carolina
Investigator: Josef Coresh Johns Hopkins University
Investigator: Matthew Davis University of Wisconsin, Madison
Investigator: Aaron Folsom University of Minnesota
Investigator: Gerardo Heiss University of North Carolina
Investigator: Daniel Jones University of Mississippi Medical Center
Investigator: Kenneth Wu Texas Health Science Center
  More Information

Additional Information:
No publications provided by National Heart, Lung, and Blood Institute (NHLBI)

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Study ID Numbers: 1001
Study First Received: May 25, 2000
Last Updated: April 13, 2009
ClinicalTrials.gov Identifier: NCT00005131     History of Changes
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Atherosclerosis
Arterial Occlusive Diseases
Heart Failure
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Arteriosclerosis
Ischemia
Coronary Disease
Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder
Coronary Artery Disease

Additional relevant MeSH terms:
Atherosclerosis
Arterial Occlusive Diseases
Heart Failure
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Arteriosclerosis
Coronary Disease
Cardiovascular Diseases
Glucose Metabolism Disorders
Coronary Artery Disease

ClinicalTrials.gov processed this record on May 07, 2009